Related references
Note: Only part of the references are listed.Autoimmunity in vitiligo: Therapeutic implications and opportunities
Binod K. Khaitan et al.
AUTOIMMUNITY REVIEWS (2022)
Evaluation of the effect of combined intralesional injection of prostaglandin F2α with narrow band UVB phototherapy in treatment of resistant cases of vitiligo
Samah A. Eldelee et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2021)
Clinical outcomes of topical bimatoprost for nonsegmental facial vitiligo: A preliminary study
Silada Kanokrungsee et al.
JOURNAL OF COSMETIC DERMATOLOGY (2021)
Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review
Nafise Yazdanian et al.
DERMATOLOGIC THERAPY (2021)
A comparative study of combined microneedling and narrowband ultraviolet B phototherapy versus their combination with topical latanoprost in the treatment of vitiligo
Yomna Mazid El-Hamd Neinaa et al.
DERMATOLOGIC THERAPY (2021)
The long-term risk of lymphoma and skin cancer did not increase after topical calcineurin inhibitor use and phototherapy in a cohort of 25,694 patients with vitiligo
Hyun Jeong Ju et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Translational Research in Vitiligo
Erica L. Katz et al.
FRONTIERS IN IMMUNOLOGY (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Combination Therapy With Microneedling and Platelet-Rich Plasma for Acne Scarring: A Systematic Review and Meta-analysis
Hua-Ching Chang et al.
DERMATOLOGIC SURGERY (2020)
Efficacy of topical latanoprost in the treatment of eyelid vitiligo: A randomized, double-blind clinical trial study
Kiomars Nowroozpoor Dailami et al.
DERMATOLOGIC THERAPY (2020)
Emerging drugs for the treatment of vitiligo
Priyanka Karagaiah et al.
EXPERT OPINION ON EMERGING DRUGS (2020)
Vitiligo, From Physiopathology to Emerging Treatments: A Review
Laure Migayron et al.
DERMATOLOGY AND THERAPY (2020)
What's New in Pigmentary Disorders
Raheel Zubair et al.
DERMATOLOGIC CLINICS (2019)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
A prospective right-left comparative study to evaluate the efficacy and tolerability of combination of NB-UVB and topical bimatoprost 0.03% eye drops versus NB-UVB given alone in patients of vitiligo vulgaris
S. Sharma et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Periorbital changes associated with prostaglandin analogs in Korean patients
Hee Weon Kim et al.
BMC OPHTHALMOLOGY (2017)
Vitiligo: An Update on Pathophysiology and Treatment Options
Reinhart Speeckaert et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2017)
Combined therapy for resistant vitiligo lesions: NB-UVB, microneedling, and topical latanoprost, showed no enhanced efficacy compared to topical latanoprost and NB-UVB
Andrija Stanimirovic et al.
DERMATOLOGIC THERAPY (2016)
A pilot comparative study of topical latanoprost and tacrolimus in combination with narrow-band ultraviolet B phototherapy and microneedling for the treatment of nonsegmental vitiligo
Igor V. Korobko et al.
DERMATOLOGIC THERAPY (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Promising alternative clinical uses of prostaglandin F2α analogs: Beyond the eyelashes
Young M. Choi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
The effect of latanoprost on vitiligo: a preliminary comparative study
Tag S. Anbar et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2015)
Adverse periocular reactions to five types of prostaglandin analogs
K. Inoue et al.
EYE (2012)
Skin pigmentation after NB-UVB and three analogues of prostaglandin F-2 alpha in guinea pigs: a comparative study
T. S. Anbar et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2010)
Evaluation of safety and efficacy of topical prostaglandin E2 in treatment of vitiligo
R. Kapoor et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Ultraviolet light exerts a major part of its therapeutic efficacy against vitiligo by production of prostaglandin E-2
M. R. Namazi
DERMATOLOGY (2008)
Effects of PGF2α, on human melanocytes and regulation of the FP receptor by ultraviolet radiation
G Scott et al.
EXPERIMENTAL CELL RESEARCH (2005)
Proteinase-activated receptor-2 stimulates prostaglandin production in keratinocytes:: Analysis of prostaglandin receptors on human melanocytes and effects of PGE2 and PGF2α on melanocyte dendricity
G Scott et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
Topical prostaglandin analog (PGE2) in vitiligo -: a preliminary study
D Parsad et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2002)
Share Paper
